Sleep Disorders Pharmaceutical and Healthcare Pipeline Review 2017

Pune, India, 13th October 2017: WiseGuyReports announced addition of new report, titled “Sleep Disorders Drug Development Pipeline Review, 2017”.

Pune, India - October 13, 2017 /MarketersMedia/ —

Summary
This report provides an overview of the pipeline landscape for sleep disorders. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for Restless Legs Syndrome, Nocturia and Insomnia, and features dormant and discontinued projects.

Restless Legs Syndrome is a neurologic disorder with a core feature of a distressing, irresistible need or urge to move the legs. Risk factors for RLS include low iron levels, kidney failure, Parkinson's disease, diabetes mellitus, rheumatoid arthritis, and pregnancy.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/2385279-sleep-disorders-drug-development-pipeline-review-2017

Nocturia, or nocturnal polyuria, describes the excessive urination during night time. Nocturia becomes more common with age and may be symptomatic of the use of diuretic substances, prescription drugs, edema from heart failure, insomnia, pain and prostate or bladder disorders.

Finally, insomnia is a sleep disorder that is characterized by difficulty in falling or staying asleep. Symptoms include difficulty falling asleep at night, waking up during the night, irritability, depression and anxiety.

The size of these pipelines ranges from eight products in restless legs syndrome and nocturia to 31 in insomnia. Across all three of these indications there is a diverse range of molecular targets due to the different pathologies of the indications. The most common targets for restless legs syndrome, nocturia and insomnia therapeutics are D2 dopamine receptor, vasopressin V2 receptor and orexin receptor, respectively.

Scope
- Which companies are the most active within the pipeline for sleep disorder therapeutics?
- Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
- To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
- What are the most important R&D milestones and data publications to have happened in the field of sleep disorders?

Reasons to buy
- Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
- Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
- Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration

Table of Content: Key Points

1 Table of Contents 4
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 Sleep Disorders Report Coverage 7
2.2 Restless Legs Syndrome - Overview 7
2.3 Nocturia - Overview 7
2.4 Insomnia - Overview 7
3 Therapeutics Development 8
3.1 Restless Legs Syndrome 8
3.2 Nocturia 11
3.3 Insomnia 14
4 Therapeutics Assessment 21
4.1 Restless Legs Syndrome 21
4.2 Nocturia 27
4.3 Insomnia 33
5 Companies Involved in Therapeutics Development 39
5.1 Restless Legs Syndrome 39
5.2 Nocturia 42
5.3 Insomnia 44
6 Dormant Projects 53
6.1 Restless Legs Syndrome 53
6.2 Nocturia 53
6.3 Insomnia 54
7 Discontinued Products 56
7.1 Restless Legs Syndrome 56
7.2 Insomnia 56
8 Product Development Milestones 58
8.1 Restless Legs Syndrome 58
8.2 Nocturia 63
…Continued

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Contact Info:
Name: NORAH TRENT
Email: Send Email
Organization: WISEGUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers
Phone: +91 841 198 5042

Source URL: https://marketersmedia.com/sleep-disorders-pharmaceutical-and-healthcare-pipeline-review-2017/250082

For more information, please visit http://www.wiseguyreports.com

Source: MarketersMedia

Release ID: 250082

Latest News

Iran detains ex-prosecutor convicted in 2009 torture case

Apr 23, 2018

TEHRAN, Iran — Iranian police have arrested a former prosecutor known as the "torturer of Tehran," who faces a two-year jail term over the death of prisoners following protests in 2009, Iranian media reported on Sunday. The official website of the judiciary, Mizanonline.com, said former Tehran prosecutor Saeed Mortazavi has been arrested, without elaborating. The semi-official Tasnim news agency said police detained Mortazavi in a villa in northern Iran, near the Caspian Sea. Mortazavi was sentenced to prison by an appeals court in December. That court found him guilty of "aiding and abetting" the torture and deaths of protesters arrested...

Merkel to Israel TV: Imperfect Iran deal better than no deal

Apr 23, 2018

JERUSALEM — German Chancellor Angela Merkel defended the Iran nuclear deal in an interview with an Israeli TV channel, saying an imperfect deal is better than no deal and that her country will "watch very closely" to ensure it is being fulfilled. Her comments were broadcast Sunday, ahead of a meeting in Washington this week with President Donald Trump who vows to withdraw from the agreement by May 12 unless U.S. and European negotiators agree to fix what he calls its serious flaws. Separately, French President Emmanuel Macron, a fellow defender of the Iran deal, begins a state visit in...

Turkish lawmakers switch parties in challenge to Erdogan

Apr 23, 2018

ISTANBUL — More than a dozen Turkish opposition lawmakers switched parties Sunday in a show of solidarity as President Recep Tayyip Erdogan's rivals scramble to challenge him in a surprise snap election that could solidify his rule. Officials from the pro-secular Republican People's Party, or CHP, said 15 of its lawmakers would join the center-right Iyi Party. The CHP, which is the main opposition party, said the decision was borne out of "democratic disposition." The snap presidential and parliamentary elections called for June 24 last week caught Turkey off guard. The opposition is in disarray as it struggles to put...

Turkish opposition leader says Erdogan will lose at polls

Apr 23, 2018

ISTANBUL, Turkey — The leader of Turkey's main opposition party predicted Saturday that voters who backed President Recep Tayyip Erdogan in the past would "side with democracy" instead of a "dictatorship" during the next elections in June. Republican People's Party leader Kemal Kilicdaroglu said he is confident of ousting Erdogan from office by winning the snap parliamentary and presidential elections "with at least 60 percent of votes" even though the party lagged in past votes. But the 69-year-old politician's optimism has weak spots. Though Kilicdaroglu says the pro-secular party, known as CHP, wasn't "surprised" by this week's announcement of early...

Natalie Portman addresses snub of 'Jewish Nobel,' backlash

Apr 23, 2018

JERUSALEM — Actress Natalie Portman has snubbed a prestigious prize known as the "Jewish Nobel," saying she did not want her attendance to be seen as an endorsement of Israeli Prime Minister Benjamin Netanyahu. Portman was to have received the award in Israel in June and said in a statement issued early Saturday that her reasons for skipping the ceremony had been mischaracterized by others, and she is not part of the BDS, a Palestinian-led global movement of boycott, divestment and sanctions against Israel. News of Portman's decision to skip the event triggered an angry backlash Friday from some in...

About Us

Get a quick look at what’s happening in the world today with in-depth analysis on international news, politics, business and technology, only in Central News Today.

Contact us: sales[at]centralnewstoday.com

Subscribe Now!